Información del autor
Autor Preedy, Victor R. |
Documentos disponibles escritos por este autor (10)
Crear una solicitud de compra Refinar búsqueda
TÃtulo de serie: Angina / TÃtulo : Scientific Basis of Healthcare : Angina Tipo de documento: documento electrónico Autores: Martin, Colin R. (1964-) ; Preedy, Victor R. Editorial: Taylor & Francis Group Fecha de publicación: 2011 Otro editor: Enfield, N.H : Science Publishers Número de páginas: x, 212 p. : Il.: ill. (some col.) Palabras clave: Angina pectoris. Myocardial infarction. Coronary heart disease. Clasificación: 362.196/122 Enlace de acceso : https://elibro-net.biblioproxy.umanizales.edu.co/es/lc/umanizales/titulos/142594 Angina /. Scientific Basis of Healthcare : Angina [documento electrónico] / Martin, Colin R. (1964-) ; Preedy, Victor R. . - Taylor & Francis Group : Enfield, N.H : Science Publishers, 2011 . - x, 212 p. : : ill. (some col.).
Palabras clave: Angina pectoris. Myocardial infarction. Coronary heart disease. Clasificación: 362.196/122 Enlace de acceso : https://elibro-net.biblioproxy.umanizales.edu.co/es/lc/umanizales/titulos/142594
TÃtulo : Biomarkers in Bone Disease Tipo de documento: documento electrónico Autores: Patel, Vinood B., ; Preedy, Victor R., Mención de edición: 1 ed. Editorial: London [UK] : Springer Fecha de publicación: 2017 Número de páginas: 186 ilustraciones, 108 ilustraciones en color. eReference. ISBN/ISSN/DL: 978-94-007-7693-7 Nota general: Libro disponible en la plataforma SpringerLink. Descarga y lectura en formatos PDF, HTML y ePub. Descarga completa o por capítulos. Idioma : Inglés (eng) Palabras clave: Cáncer OncologÃa FarmacologÃa BiologÃa del cáncer Clasificación: 571.978 Resumen: Hay muchas condiciones que afectan el sistema esquelético. A nivel mundial, la osteoartritis por sà sola afecta entre el 10 y el 15 por ciento de las personas mayores de 60 años y en algunos paÃses más del 30 al 50 por ciento de las mujeres posmenopáusicas tendrán osteopenia u osteoporosis. Con el creciente envejecimiento de la población, mantener la salud esquelética es particularmente importante. Las fracturas en las personas mayores, por ejemplo, pueden provocar muertes prematuras. Por tanto, es imperativo que se haga un uso adecuado de las plataformas de biomarcadores convencionales, nuevas y emergentes. Biomarkers in Bone Disease adopta un enfoque holÃstico al combinar información sobre diferentes afecciones que afectan el sistema esquelético y el uso de biomarcadores. Los biomarcadores se describen en términos de analitos, técnicas, plataformas y aplicaciones convencionales, nuevos y emergentes. Cubre los últimos conocimientos, tendencias e innovaciones. Se describen nuevas plataformas que combinan avances en ciencias biomédicas, fÃsica, informática y quÃmica. Nota de contenido: Serum uric acid and biomarkers of lumbar spine bone mineral density -- Use of alkaline phosphatase (ALP) activity and disease severity to determine secular changes in bone disease as applied to Paget's disease of the bone -- Bone Turnover and Spinal Cord Injury -- Bone-related proteins as markers in vascular remodelling --  Serum Sclerostin as Biomarker in Osteogenesis Imperfecta -- Parathyroid Hormone (PTH) assays and applications to bone disease: Overview on methodology -- Registered microcomputed tomography data as a four dimensional imaging biomarker of bone formation and resorption -- Use of bone biomarkers after weight loss: Example of bariatric surgery -- Adiponectin as biomarker of osteoporosis -- Effect of statins on bone turnover markers -- Chitinases as biomarkers in bone studies -- Hormone relaxin as biomarker for bone health and disease -- Panoramic radiomorphometric indices of mandible: Biomarker for osteoporosis -- Hip Fracture Risk is Strongly Related to Circulating Levels of the Advanced Glycation End-product Carboxy-Methyl Lysine (CML) -- Effects of glucose on bone markers: Overview of current knowledge with focus on diabetes, glucose, and bone markers -- Traditional medicine and use of bone biomarkers -- Osteosarcoma Biomarkers discovery using "omics" approaches -- Creatine kinase as biomarker in osteogenesis imperfecta -- Ameloblastin as biomarker of bone -- Biomarker genes in autosomal dominant osteopetrosis type II (ADO II) -- Bone markers in Rett syndrome -- Bone Specific Alkaline Phosphatase and Exercise -- Bone turnover markers and glucocorticoid treatments -- Overview of biochemical markers of bone metabolism -- Biomarkers of natural radionuclides in bone and teeth -- Bone markers throughout sexual development: epidemiological significance and population-based findings -- Parathyroid hormone (PTH) and the relationship between PTH and bone health: structure, physiology, actions, and ethnicity -- Quantitative ultrasound as a biomarker tool in newborn infants for bone.-Bone biomarkers in gestational hypertension -- Bone biomarkers in intrauterine growth restriction -- Raman spectroscopy as a biomarker-investigative tool in bone metabolism -- Pentosidine as a biomarker for poor bone quality and elevated fracture risk -- Spine bone texture and the trabecular bone score (TBS) -- Bone biomarkers in HIV -- Bone Biomarkers Related to Osteoarthritis -- Dietary Soy Phytoestrogens and Biomarkers of Osteoporosis -- Utilisation and reference values of osteocalcin and procollagen type 1 n-propeptide -- Analysis of integrin alpha2beta1 (a2b1) expression as a biomarker of skeletal metastasis -- Circulating Sclerostin in Bone Sclerosing Disorders -- Pentraxin 3 as a bone biomarker -- Sirtuins as markers of bone disease: a focus on osteoarthritis and osteoporosis -- Tartarate resistant acid phosphatase as a biomarker of bone remodeling. . Tipo de medio : Computadora Summary : There are many conditions that affect the skeletal system. On a worldwide basis, osteoarthritis alone affects 10%-15 percent of those over 60 years of age and in some countries more than 30-50% of postmenopausal women will have osteopenia or osteoporosis. With the increasing ageing population, maintaining skeletal health is particularly important. Fractures in the aged, for example, can lead to premature deaths. It is therefore imperative that appropriate use is made of conventional, new and emerging biomarker platforms. Biomarkers in Bone Disease embraces a holistic approach by combining information on different conditions that affect the skeletal system and the use of biomarkers. Biomarkers are described in terms of conventional, new and emerging analytes, techniques, platforms and applications. It covers the latest knowledge, trends and innovations. New platforms are described which combine advances in biomedical sciences, physics, computing and chemistry. Enlace de acceso : https://link-springer-com.biblioproxy.umanizales.edu.co/referencework/10.1007/97 [...] Biomarkers in Bone Disease [documento electrónico] / Patel, Vinood B., ; Preedy, Victor R., . - 1 ed. . - London [UK] : Springer, 2017 . - 186 ilustraciones, 108 ilustraciones en color. eReference.
ISBN : 978-94-007-7693-7
Libro disponible en la plataforma SpringerLink. Descarga y lectura en formatos PDF, HTML y ePub. Descarga completa o por capítulos.
Idioma : Inglés (eng)
Palabras clave: Cáncer OncologÃa FarmacologÃa BiologÃa del cáncer Clasificación: 571.978 Resumen: Hay muchas condiciones que afectan el sistema esquelético. A nivel mundial, la osteoartritis por sà sola afecta entre el 10 y el 15 por ciento de las personas mayores de 60 años y en algunos paÃses más del 30 al 50 por ciento de las mujeres posmenopáusicas tendrán osteopenia u osteoporosis. Con el creciente envejecimiento de la población, mantener la salud esquelética es particularmente importante. Las fracturas en las personas mayores, por ejemplo, pueden provocar muertes prematuras. Por tanto, es imperativo que se haga un uso adecuado de las plataformas de biomarcadores convencionales, nuevas y emergentes. Biomarkers in Bone Disease adopta un enfoque holÃstico al combinar información sobre diferentes afecciones que afectan el sistema esquelético y el uso de biomarcadores. Los biomarcadores se describen en términos de analitos, técnicas, plataformas y aplicaciones convencionales, nuevos y emergentes. Cubre los últimos conocimientos, tendencias e innovaciones. Se describen nuevas plataformas que combinan avances en ciencias biomédicas, fÃsica, informática y quÃmica. Nota de contenido: Serum uric acid and biomarkers of lumbar spine bone mineral density -- Use of alkaline phosphatase (ALP) activity and disease severity to determine secular changes in bone disease as applied to Paget's disease of the bone -- Bone Turnover and Spinal Cord Injury -- Bone-related proteins as markers in vascular remodelling --  Serum Sclerostin as Biomarker in Osteogenesis Imperfecta -- Parathyroid Hormone (PTH) assays and applications to bone disease: Overview on methodology -- Registered microcomputed tomography data as a four dimensional imaging biomarker of bone formation and resorption -- Use of bone biomarkers after weight loss: Example of bariatric surgery -- Adiponectin as biomarker of osteoporosis -- Effect of statins on bone turnover markers -- Chitinases as biomarkers in bone studies -- Hormone relaxin as biomarker for bone health and disease -- Panoramic radiomorphometric indices of mandible: Biomarker for osteoporosis -- Hip Fracture Risk is Strongly Related to Circulating Levels of the Advanced Glycation End-product Carboxy-Methyl Lysine (CML) -- Effects of glucose on bone markers: Overview of current knowledge with focus on diabetes, glucose, and bone markers -- Traditional medicine and use of bone biomarkers -- Osteosarcoma Biomarkers discovery using "omics" approaches -- Creatine kinase as biomarker in osteogenesis imperfecta -- Ameloblastin as biomarker of bone -- Biomarker genes in autosomal dominant osteopetrosis type II (ADO II) -- Bone markers in Rett syndrome -- Bone Specific Alkaline Phosphatase and Exercise -- Bone turnover markers and glucocorticoid treatments -- Overview of biochemical markers of bone metabolism -- Biomarkers of natural radionuclides in bone and teeth -- Bone markers throughout sexual development: epidemiological significance and population-based findings -- Parathyroid hormone (PTH) and the relationship between PTH and bone health: structure, physiology, actions, and ethnicity -- Quantitative ultrasound as a biomarker tool in newborn infants for bone.-Bone biomarkers in gestational hypertension -- Bone biomarkers in intrauterine growth restriction -- Raman spectroscopy as a biomarker-investigative tool in bone metabolism -- Pentosidine as a biomarker for poor bone quality and elevated fracture risk -- Spine bone texture and the trabecular bone score (TBS) -- Bone biomarkers in HIV -- Bone Biomarkers Related to Osteoarthritis -- Dietary Soy Phytoestrogens and Biomarkers of Osteoporosis -- Utilisation and reference values of osteocalcin and procollagen type 1 n-propeptide -- Analysis of integrin alpha2beta1 (a2b1) expression as a biomarker of skeletal metastasis -- Circulating Sclerostin in Bone Sclerosing Disorders -- Pentraxin 3 as a bone biomarker -- Sirtuins as markers of bone disease: a focus on osteoarthritis and osteoporosis -- Tartarate resistant acid phosphatase as a biomarker of bone remodeling. . Tipo de medio : Computadora Summary : There are many conditions that affect the skeletal system. On a worldwide basis, osteoarthritis alone affects 10%-15 percent of those over 60 years of age and in some countries more than 30-50% of postmenopausal women will have osteopenia or osteoporosis. With the increasing ageing population, maintaining skeletal health is particularly important. Fractures in the aged, for example, can lead to premature deaths. It is therefore imperative that appropriate use is made of conventional, new and emerging biomarker platforms. Biomarkers in Bone Disease embraces a holistic approach by combining information on different conditions that affect the skeletal system and the use of biomarkers. Biomarkers are described in terms of conventional, new and emerging analytes, techniques, platforms and applications. It covers the latest knowledge, trends and innovations. New platforms are described which combine advances in biomedical sciences, physics, computing and chemistry. Enlace de acceso : https://link-springer-com.biblioproxy.umanizales.edu.co/referencework/10.1007/97 [...]
TÃtulo : Biomarkers in Liver Disease Tipo de documento: documento electrónico Autores: Patel, Vinood B., ; Preedy, Victor R., Mención de edición: 1 ed. Editorial: London [UK] : Springer Fecha de publicación: 2017 Número de páginas: 162 ilustraciones, 110 ilustraciones en color. eReference. ISBN/ISSN/DL: 978-94-007-7675-3 Nota general: Libro disponible en la plataforma SpringerLink. Descarga y lectura en formatos PDF, HTML y ePub. Descarga completa o por capítulos. Idioma : Inglés (eng) Palabras clave: Cáncer OncologÃa FarmacologÃa BiologÃa del cáncer Clasificación: 571.978 Resumen: Existen numerosos tipos de enfermedades hepáticas que pueden deberse a agentes tóxicos (como el alcohol o las drogas), agentes infecciosos, incluidos virus, afecciones congénitas e incluso malos hábitos alimentarios. Se ha sugerido que existen más de 100 tipos diferentes. Como las consecuencias de la insuficiencia hepática pueden ser devastadoras, es importante realizar un diagnóstico y seguimiento adecuados. Gran parte de esta caracterización implica el uso de indicadores biológicos, es decir, biomarcadores. Biomarkers in Liver Disease adopta un enfoque holÃstico al combinar información detallada sobre diferentes afecciones que afectan el hÃgado y el uso de biomarcadores. Los biomarcadores se describen en términos de analitos, técnicas, plataformas y aplicaciones convencionales, nuevos y emergentes. Cubre los últimos conocimientos, tendencias e innovaciones. Se describen nuevas plataformas que combinan avances en ciencias biomédicas, fÃsica, informática y quÃmica. Nota de contenido: Liver biomarkers and their applications to nutritional interventions in animal studies -- AST-to-platelet ratio index (APRI) as marker in liver disease.-Inflammatory biomarkers in ascites -- Biomarkers for hepatocellular carcinoma in East Asia -- Liver disease and acylcarnitines as mechanistic biomarkers.-Type VI Collagen: Biological Functions and its Neo-epitope as Hepatic Fibrosis Biomarker -- Fibrinogen α-chain as a serum marker of liver disease -- Monocyte chemotactic protein-1 (cytokine, receptors,and gene polymorphisms) in hepatitis -- Biomarkers for Recurrence of Hepatocellular Carcinoma.-Graft-derived cell-free DNA as a biomarker in liver transplantation -- Serum sialic acid as a biomarker in liver disease -- CD133 and EpCAM as Biomarkers in Liver Diseases -- Traditional markers in liver disease -- Biomarkers of extracellular matrix remodeling in liver diseases -- Squamous Cell Carcinoma Antigen- Immunoglobulin M (SCCA-IgM) as biomarker in liver disease: biological aspects and clinicalapplications -- microRNA-155 and microRNA-196b in hepatitis C virus infection -- Immunological biomarkers in liver transplantation -- Phosphatidylethanol and alcohol use in liver disease patients -- Interaction of sialyltransferases, sialidases and sialic acids in liver diseases and applications to biomarker discovery -- Biomarkers to monitor graft function following liver transplantation -- YKL-40 as a biomarker of liver diseases -- Peripheral venous, portal venous, hepatic venous, arterial and intrahepatic cytokine levels as biomarkers and functional correlations -- Histological Biomarkers of Non-Alcoholic Fatty Liver Disease -- Vascular cell adhesion molecule-1 (vcam-1) expression in liver disease -- Bilirubin as a biomarker in liver disease -- Hydroxyproline as a biomarker in liver disease -- Genetic biomarkers of paracetamol-induced acute liver failure -- PNPLA3 polymorphism and Nonalcoholic Fatty Liver Disease -- Hepascore and it's application to liver disease -- Model for End-Stage Liver Disease (MELD) Score as a Biomarker -- Biomarkers in focus: Alanine Aminotransferase -- PTX3 as a biomarker of liver disease. Tipo de medio : Computadora Summary : There are numerous types of liver disease that may be due to toxic agents (such as alcohol or drugs), infectious agents including viruses, congenital conditions and even poor dietary patterns. It has been suggested that there are over 100 different types. As the consequences of liver failure can be devastating it is important that appropriate diagnosis and monitoring is carried out. Much of this characterisation entails the use of biological indicators, i.e biomarkers. Biomarkers in Liver Disease embraces a holistic approach by combining detailed information on different conditions that affect the liver and the use of biomarkers. Biomarkers are described in terms of conventional, new and emerging analytes, techniques, platforms and applications. It covers the latest knowledge, trends and innovations. New platforms are described which combine advances in biomedical sciences, physics, computing and chemistry. Enlace de acceso : https://link-springer-com.biblioproxy.umanizales.edu.co/referencework/10.1007/97 [...] Biomarkers in Liver Disease [documento electrónico] / Patel, Vinood B., ; Preedy, Victor R., . - 1 ed. . - London [UK] : Springer, 2017 . - 162 ilustraciones, 110 ilustraciones en color. eReference.
ISBN : 978-94-007-7675-3
Libro disponible en la plataforma SpringerLink. Descarga y lectura en formatos PDF, HTML y ePub. Descarga completa o por capítulos.
Idioma : Inglés (eng)
Palabras clave: Cáncer OncologÃa FarmacologÃa BiologÃa del cáncer Clasificación: 571.978 Resumen: Existen numerosos tipos de enfermedades hepáticas que pueden deberse a agentes tóxicos (como el alcohol o las drogas), agentes infecciosos, incluidos virus, afecciones congénitas e incluso malos hábitos alimentarios. Se ha sugerido que existen más de 100 tipos diferentes. Como las consecuencias de la insuficiencia hepática pueden ser devastadoras, es importante realizar un diagnóstico y seguimiento adecuados. Gran parte de esta caracterización implica el uso de indicadores biológicos, es decir, biomarcadores. Biomarkers in Liver Disease adopta un enfoque holÃstico al combinar información detallada sobre diferentes afecciones que afectan el hÃgado y el uso de biomarcadores. Los biomarcadores se describen en términos de analitos, técnicas, plataformas y aplicaciones convencionales, nuevos y emergentes. Cubre los últimos conocimientos, tendencias e innovaciones. Se describen nuevas plataformas que combinan avances en ciencias biomédicas, fÃsica, informática y quÃmica. Nota de contenido: Liver biomarkers and their applications to nutritional interventions in animal studies -- AST-to-platelet ratio index (APRI) as marker in liver disease.-Inflammatory biomarkers in ascites -- Biomarkers for hepatocellular carcinoma in East Asia -- Liver disease and acylcarnitines as mechanistic biomarkers.-Type VI Collagen: Biological Functions and its Neo-epitope as Hepatic Fibrosis Biomarker -- Fibrinogen α-chain as a serum marker of liver disease -- Monocyte chemotactic protein-1 (cytokine, receptors,and gene polymorphisms) in hepatitis -- Biomarkers for Recurrence of Hepatocellular Carcinoma.-Graft-derived cell-free DNA as a biomarker in liver transplantation -- Serum sialic acid as a biomarker in liver disease -- CD133 and EpCAM as Biomarkers in Liver Diseases -- Traditional markers in liver disease -- Biomarkers of extracellular matrix remodeling in liver diseases -- Squamous Cell Carcinoma Antigen- Immunoglobulin M (SCCA-IgM) as biomarker in liver disease: biological aspects and clinicalapplications -- microRNA-155 and microRNA-196b in hepatitis C virus infection -- Immunological biomarkers in liver transplantation -- Phosphatidylethanol and alcohol use in liver disease patients -- Interaction of sialyltransferases, sialidases and sialic acids in liver diseases and applications to biomarker discovery -- Biomarkers to monitor graft function following liver transplantation -- YKL-40 as a biomarker of liver diseases -- Peripheral venous, portal venous, hepatic venous, arterial and intrahepatic cytokine levels as biomarkers and functional correlations -- Histological Biomarkers of Non-Alcoholic Fatty Liver Disease -- Vascular cell adhesion molecule-1 (vcam-1) expression in liver disease -- Bilirubin as a biomarker in liver disease -- Hydroxyproline as a biomarker in liver disease -- Genetic biomarkers of paracetamol-induced acute liver failure -- PNPLA3 polymorphism and Nonalcoholic Fatty Liver Disease -- Hepascore and it's application to liver disease -- Model for End-Stage Liver Disease (MELD) Score as a Biomarker -- Biomarkers in focus: Alanine Aminotransferase -- PTX3 as a biomarker of liver disease. Tipo de medio : Computadora Summary : There are numerous types of liver disease that may be due to toxic agents (such as alcohol or drugs), infectious agents including viruses, congenital conditions and even poor dietary patterns. It has been suggested that there are over 100 different types. As the consequences of liver failure can be devastating it is important that appropriate diagnosis and monitoring is carried out. Much of this characterisation entails the use of biological indicators, i.e biomarkers. Biomarkers in Liver Disease embraces a holistic approach by combining detailed information on different conditions that affect the liver and the use of biomarkers. Biomarkers are described in terms of conventional, new and emerging analytes, techniques, platforms and applications. It covers the latest knowledge, trends and innovations. New platforms are described which combine advances in biomedical sciences, physics, computing and chemistry. Enlace de acceso : https://link-springer-com.biblioproxy.umanizales.edu.co/referencework/10.1007/97 [...]
TÃtulo : Biosensors and Environmental Health Tipo de documento: documento electrónico Autores: Preedy, Victor R., ; Patel, Vinood B., Editorial: Taylor & Francis Group Fecha de publicación: 2012 Número de páginas: 1 online resource (383 pages, 9 unnumbered pages of plates) : Il.: illustrations ISBN/ISSN/DL: 9781466565661 Palabras clave: Biosensors. Environmental health. Environmental toxicology. Pollution Measurement. Clasificación: 610.28 Enlace de acceso : https://elibro-net.biblioproxy.umanizales.edu.co/es/lc/umanizales/titulos/147489 Biosensors and Environmental Health [documento electrónico] / Preedy, Victor R., ; Patel, Vinood B., . - Taylor & Francis Group, 2012 . - 1 online resource (383 pages, 9 unnumbered pages of plates) : : illustrations.
ISBN : 9781466565661
Palabras clave: Biosensors. Environmental health. Environmental toxicology. Pollution Measurement. Clasificación: 610.28 Enlace de acceso : https://elibro-net.biblioproxy.umanizales.edu.co/es/lc/umanizales/titulos/147489
TÃtulo : Diet, Nutrition, and Fetal Programming Tipo de documento: documento electrónico Autores: Rajendram, Rajkumar, ; Preedy, Victor R., ; Patel, Vinood B., Mención de edición: 1 ed. Editorial: [s.l.] : Springer Fecha de publicación: 2017 Número de páginas: XXXIX, 621 p. 154 ilustraciones, 111 ilustraciones en color. ISBN/ISSN/DL: 978-3-319-60289-9 Nota general: Libro disponible en la plataforma SpringerLink. Descarga y lectura en formatos PDF, HTML y ePub. Descarga completa o por capítulos. Idioma : Inglés (eng) Palabras clave: BioquÃmica clÃnica GinecologÃa BioquÃmica Médica Clasificación: 613.2 Resumen: Este volumen ofrece la cobertura más completa sobre programación fetal. Los capÃtulos están escritos por autores de prestigio nacional e internacional, lÃderes en el campo y creadores de tendencias. La relevancia clÃnica de la investigación actual se enfatiza en cada capÃtulo, que también contiene puntos clave, palabras clave y resúmenes concisos para facilitar el aprendizaje. La programación fetal afecta las condiciones en el perÃodo posnatal inmediato, asà como en la vida posterior y en la edad adulta. Estas condiciones incluyen enfermedad cardiovascular, hipertensión franca, accidente cerebrovascular, dislipidemia, coagulopatÃa, sÃndrome metabólico de resistencia a la insulina aumentada, diabetes tipo 2, leucemia, cáncer testicular, cáncer de próstata, cáncer de mama, sÃndrome de ovario poliquÃstico, pubertad precoz, función inmune deteriorada, enfermedad renal. enfermedades, enfermedades pulmonares y osteoporosis. También se han informado neuropatologÃas, deficiencias mentales y conductuales, esquizofrenia y depresión en adultos que estuvieron expuestos a deficiencias nutricionales en el útero. Dieta, nutrición y programación fetal proporciona una descripción general de los efectos de la programación fetal sobre las enfermedades, y una mirada integral a los factores de nutrición materna y los efectos de la programación fetal sobre el cerebro y el comportamiento, y la fisiologÃa y las enfermedades. También proporciona una mirada en profundidad a las restricciones y suplementos de nutrientes especÃficos sobre la fisiologÃa y la enfermedad, los efectos de la enfermedad materna en la programación fetal, los mecanismos de programación y una sección especial sobre los aspectos y polÃticas internacionales sobre la programación fetal. Nota de contenido: Part I: Maternal Diet, Health and the Fetus: General Considerations -- Prenatal Maternal Stress in the Context: Maternal Stress Physiology, Immunology, Neuroendocrinology, Nutrition and Infant Development -- The Effects of Parental Diet on Fetal Programming of Stress-Related Brain Regions and Behaviors: Implications for Development of Neuropsychiatric Disorders -- Maternal Nutrition and Cognition -- Maternal Characteristics predisposing to Fetal Growth Restriction -- Maternal Insulin Sensitivity and Fetal Brain Activity -- Part II: Maternal Undernutrition and Protein Restriction: Effects on Fetus -- Dietary Restriction and the Endocrine Profiles in Offspring and Adults -- Maternal Undernutrition and Visceral Adiposity -- Maternal Undernutrition and Long-term Effects on Hepatic Function -- Maternal Protein Restriction and its Effects on Heart -- Effects of Maternal Protein Restriction on Nephrogenesis and Adult and Aging Kidney -- Maternal Protein Restriction and Effects on Behavior and Memory in Offspring -- Part III: Effects of Obesity, High Fat Diet and Junk Food on Fetal Outcomes -- Trends in Obesity and Implications for the Fetus -- Maternal Obesity and Implications for Fetal Programming -- Ethnicity, Obesity, and Pregnancy Outcomes on Fetal Programming -- Obesogenic Programming of Foetal Hepatic Metabolism by MircoRNAs -- Impacts of Maternal High Fat Diet on Stree-related Behavior and the Endocrine Response to Stress in Offspring -- Materna; Junk Food Diets: The Effects on Offspring Fat Mass and Food Preferences -- Part IV: Specific Dietary Components -- Maternal Fish Intake During Pregnancy and Effects on the Offspring -- Maternal Fish Oil Intake and Insulin Resistance in the Offspring -- Maternal n-3 Fatty Acids and Blood Pressure in Children -- Maternal Folate, Methyl Donors, One Carbon Metabolism, Vitamin B12 and Choline in Fetal Programming -- Maternal Taurine Supplementation Prevents Misprogramming -- Fetal Programming: Maternal Diets, Tryptophan and Postnatal Development -- Intrauterine Programming and Effects of Caffeine -- Part V: International Aspects and Policies -- Famines, Pregnancy and Effect on the Adults -- Maternal Malnutrition, Fetal Programming, Outcomes and Strategies in India -- Maternal Nutritional Factors Dictating Birth Weights: African Perspectives -- Maternal Nutrition in Ireland: Issues of Public Concern -- Maternal Malnutrition, Fetal Programming, Outcomes, and Implications of Environmental Factors in Japan -- Part VI: Effects of Fetal Programming in Childhood and Adulthood -- Growth Criteria and Predictors of Fetal Programming -- Effects of Fetal Programming on Metabolic Syndrome -- Fetal Programming of Food Preferences and Feeding Behavior -- Effects of Fetal Programming on Osteoporosis -- Childhood Sleep after Fetal Growth Restriction -- Part VII: Mechanisms of Programming -- Biomarkers of Abnormal Birth Weight in Pregnancy -- Mechanisms of Programming: Pancreatic Islets and Fetal Programming -- Pancratic GABA and Serotonin Actions in the Pancreas and Fetal Programming of Metabolism -- Maternal Malnutrition, Glucocorticoids and Fetal Programming: A Role for Placental 11β-hydroxysteroid dehydrogenase Type 2 -- High-fat Diet and Fetal Programming: Use of p66Shc Knockouts and Implications for Human Kind -- Fetal Programming of Telomere Biology: Role of Maternal Nutrition, Obstetric Risk Factors and Suboptimal Birth Outcomes. Part VIII: Resources -- Current Research and Recommended Resources on Fetal Nutrition. Tipo de medio : Computadora Summary : This volume offers the most comprehensive coverage on fetal programming. Chapters are written by authors of international and national standing, leaders in the field and trendsetters. The clinical relevance of the current research is emphasized in each chapter, which also contains key points, key words, and concise summaries for ease of learning. Fetal programming affects conditions in the immediate postnatal period, as well as in later life and adulthood. These conditions include cardiovascular disease, frank hypertension, stroke, dyslipidemia, coagulopathy, increased insulin resistance-metabolic syndrome, type-2 diabetes, leukemia, testicular cancer, prostate cancer, breast cancer, polycystic ovary syndrome, precocious puberty, impaired immune function, renal disease, lung disease, and osteoporosis. Neuropathologies, behavioral and mental deficiencies, schizophrenia, and depression have also been reported in adults who were exposed to nutritional inadequacies in utero. Diet, Nutrition and Fetal Programming provides an overview on the effects of fetal programming on disease, and comprehensive looks at maternal nutrition factors and fetal programming effects on brain and behavior, and physiology and disease. It also provides an in depth look at specific nutrient restrictions and supplements on physiology and disease, the effects of maternal disease on fetal programming, mechanisms of programming, and a special section on the international aspects and policies on fetal programming. Enlace de acceso : https://link-springer-com.biblioproxy.umanizales.edu.co/referencework/10.1007/97 [...] Diet, Nutrition, and Fetal Programming [documento electrónico] / Rajendram, Rajkumar, ; Preedy, Victor R., ; Patel, Vinood B., . - 1 ed. . - [s.l.] : Springer, 2017 . - XXXIX, 621 p. 154 ilustraciones, 111 ilustraciones en color.
ISBN : 978-3-319-60289-9
Libro disponible en la plataforma SpringerLink. Descarga y lectura en formatos PDF, HTML y ePub. Descarga completa o por capítulos.
Idioma : Inglés (eng)
Palabras clave: BioquÃmica clÃnica GinecologÃa BioquÃmica Médica Clasificación: 613.2 Resumen: Este volumen ofrece la cobertura más completa sobre programación fetal. Los capÃtulos están escritos por autores de prestigio nacional e internacional, lÃderes en el campo y creadores de tendencias. La relevancia clÃnica de la investigación actual se enfatiza en cada capÃtulo, que también contiene puntos clave, palabras clave y resúmenes concisos para facilitar el aprendizaje. La programación fetal afecta las condiciones en el perÃodo posnatal inmediato, asà como en la vida posterior y en la edad adulta. Estas condiciones incluyen enfermedad cardiovascular, hipertensión franca, accidente cerebrovascular, dislipidemia, coagulopatÃa, sÃndrome metabólico de resistencia a la insulina aumentada, diabetes tipo 2, leucemia, cáncer testicular, cáncer de próstata, cáncer de mama, sÃndrome de ovario poliquÃstico, pubertad precoz, función inmune deteriorada, enfermedad renal. enfermedades, enfermedades pulmonares y osteoporosis. También se han informado neuropatologÃas, deficiencias mentales y conductuales, esquizofrenia y depresión en adultos que estuvieron expuestos a deficiencias nutricionales en el útero. Dieta, nutrición y programación fetal proporciona una descripción general de los efectos de la programación fetal sobre las enfermedades, y una mirada integral a los factores de nutrición materna y los efectos de la programación fetal sobre el cerebro y el comportamiento, y la fisiologÃa y las enfermedades. También proporciona una mirada en profundidad a las restricciones y suplementos de nutrientes especÃficos sobre la fisiologÃa y la enfermedad, los efectos de la enfermedad materna en la programación fetal, los mecanismos de programación y una sección especial sobre los aspectos y polÃticas internacionales sobre la programación fetal. Nota de contenido: Part I: Maternal Diet, Health and the Fetus: General Considerations -- Prenatal Maternal Stress in the Context: Maternal Stress Physiology, Immunology, Neuroendocrinology, Nutrition and Infant Development -- The Effects of Parental Diet on Fetal Programming of Stress-Related Brain Regions and Behaviors: Implications for Development of Neuropsychiatric Disorders -- Maternal Nutrition and Cognition -- Maternal Characteristics predisposing to Fetal Growth Restriction -- Maternal Insulin Sensitivity and Fetal Brain Activity -- Part II: Maternal Undernutrition and Protein Restriction: Effects on Fetus -- Dietary Restriction and the Endocrine Profiles in Offspring and Adults -- Maternal Undernutrition and Visceral Adiposity -- Maternal Undernutrition and Long-term Effects on Hepatic Function -- Maternal Protein Restriction and its Effects on Heart -- Effects of Maternal Protein Restriction on Nephrogenesis and Adult and Aging Kidney -- Maternal Protein Restriction and Effects on Behavior and Memory in Offspring -- Part III: Effects of Obesity, High Fat Diet and Junk Food on Fetal Outcomes -- Trends in Obesity and Implications for the Fetus -- Maternal Obesity and Implications for Fetal Programming -- Ethnicity, Obesity, and Pregnancy Outcomes on Fetal Programming -- Obesogenic Programming of Foetal Hepatic Metabolism by MircoRNAs -- Impacts of Maternal High Fat Diet on Stree-related Behavior and the Endocrine Response to Stress in Offspring -- Materna; Junk Food Diets: The Effects on Offspring Fat Mass and Food Preferences -- Part IV: Specific Dietary Components -- Maternal Fish Intake During Pregnancy and Effects on the Offspring -- Maternal Fish Oil Intake and Insulin Resistance in the Offspring -- Maternal n-3 Fatty Acids and Blood Pressure in Children -- Maternal Folate, Methyl Donors, One Carbon Metabolism, Vitamin B12 and Choline in Fetal Programming -- Maternal Taurine Supplementation Prevents Misprogramming -- Fetal Programming: Maternal Diets, Tryptophan and Postnatal Development -- Intrauterine Programming and Effects of Caffeine -- Part V: International Aspects and Policies -- Famines, Pregnancy and Effect on the Adults -- Maternal Malnutrition, Fetal Programming, Outcomes and Strategies in India -- Maternal Nutritional Factors Dictating Birth Weights: African Perspectives -- Maternal Nutrition in Ireland: Issues of Public Concern -- Maternal Malnutrition, Fetal Programming, Outcomes, and Implications of Environmental Factors in Japan -- Part VI: Effects of Fetal Programming in Childhood and Adulthood -- Growth Criteria and Predictors of Fetal Programming -- Effects of Fetal Programming on Metabolic Syndrome -- Fetal Programming of Food Preferences and Feeding Behavior -- Effects of Fetal Programming on Osteoporosis -- Childhood Sleep after Fetal Growth Restriction -- Part VII: Mechanisms of Programming -- Biomarkers of Abnormal Birth Weight in Pregnancy -- Mechanisms of Programming: Pancreatic Islets and Fetal Programming -- Pancratic GABA and Serotonin Actions in the Pancreas and Fetal Programming of Metabolism -- Maternal Malnutrition, Glucocorticoids and Fetal Programming: A Role for Placental 11β-hydroxysteroid dehydrogenase Type 2 -- High-fat Diet and Fetal Programming: Use of p66Shc Knockouts and Implications for Human Kind -- Fetal Programming of Telomere Biology: Role of Maternal Nutrition, Obstetric Risk Factors and Suboptimal Birth Outcomes. Part VIII: Resources -- Current Research and Recommended Resources on Fetal Nutrition. Tipo de medio : Computadora Summary : This volume offers the most comprehensive coverage on fetal programming. Chapters are written by authors of international and national standing, leaders in the field and trendsetters. The clinical relevance of the current research is emphasized in each chapter, which also contains key points, key words, and concise summaries for ease of learning. Fetal programming affects conditions in the immediate postnatal period, as well as in later life and adulthood. These conditions include cardiovascular disease, frank hypertension, stroke, dyslipidemia, coagulopathy, increased insulin resistance-metabolic syndrome, type-2 diabetes, leukemia, testicular cancer, prostate cancer, breast cancer, polycystic ovary syndrome, precocious puberty, impaired immune function, renal disease, lung disease, and osteoporosis. Neuropathologies, behavioral and mental deficiencies, schizophrenia, and depression have also been reported in adults who were exposed to nutritional inadequacies in utero. Diet, Nutrition and Fetal Programming provides an overview on the effects of fetal programming on disease, and comprehensive looks at maternal nutrition factors and fetal programming effects on brain and behavior, and physiology and disease. It also provides an in depth look at specific nutrient restrictions and supplements on physiology and disease, the effects of maternal disease on fetal programming, mechanisms of programming, and a special section on the international aspects and policies on fetal programming. Enlace de acceso : https://link-springer-com.biblioproxy.umanizales.edu.co/referencework/10.1007/97 [...] Nutrition and Diet in Maternal Diabetes / Rajendram, Rajkumar ; Preedy, Victor R. ; Patel, Vinood B.
PermalinkPermalink
